Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 Jul 27;326(4):360. doi: 10.1001/jama.2021.9741

Incorrect Figure

PMCID: PMC8317000  PMID: 34313707

In the Original Investigation titled “Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Review,” published in the February 19, 2014,1 issue of JAMA, the graphs in Figure 2 were reversed. This article was corrected online.

Reference

  • 1.Morillo CA, Verma A, Connolly SJ, et al. ; RAAFT-2 Investigators . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a review. JAMA. 2014;311(7):692-699. doi: 10.1001/jama.2014.467 [DOI] [PubMed] [Google Scholar]

Articles from JAMA are provided here courtesy of American Medical Association

RESOURCES